Product Information
MINOCYCLINE ER 135 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $3.2955 per EA under NDC 67877057730. Its NADAC has been published 57 times since Jun 19, 2024.
The High Outlier badge above means this manufacturer's average price in the Minocycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
135 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877057730
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
7/17/2024
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204453On Market Since
9/30/2016
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE ER 135 MG TABLET has been published 57 times since Jun 19, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2955 per EA |
|---|---|
| All-time high | $3.2955 (Jul 16, 2025) |
| All-time low | $3.2955 (Jun 19, 2024) |
| 52-week high | $3.2955 |
| 52-week low | $3.2955 |
| Median price | $3.2955 |
| Average price | $3.2955 |
| Largest weekly change | 0.0% (Jun 26, 2024) |
| Weeks tracked | 57 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Minocycline Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MINOCYCLINE ER 135 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE ER 135 MG TABLET, manufactured by Ascend Laboratories, LLC, is $3.2955 per EA (NDC 67877057730), effective Jul 16, 2025.
How has the price of MINOCYCLINE ER 135 MG TABLET changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE ER 135 MG TABLET has held within roughly two percent of its current level. It has been tracked across 57 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE ER 135 MG TABLET?
Since Jun 19, 2024, the NADAC for MINOCYCLINE ER 135 MG TABLET has ranged from a low of $3.2955 (Jun 19, 2024) to a high of $3.2955 (Jul 16, 2025), with a median of $3.2955 per EA.
Are there cheaper alternatives to MINOCYCLINE ER 135 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MINOCYCLINE ER 135 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures MINOCYCLINE ER 135 MG TABLET?
MINOCYCLINE ER 135 MG TABLET (NDC 67877057730) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification